Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX-SIRIUS STUDY I (the IFX-SIRIUS STUDY II): A clinical, ultrasound, and biomarker-based effectiveness after discontinuation and reinitiation of biosimilar infliximab.

Saved in:
Bibliographic Details
Title: Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX-SIRIUS STUDY I (the IFX-SIRIUS STUDY II): A clinical, ultrasound, and biomarker-based effectiveness after discontinuation and reinitiation of biosimilar infliximab.
Authors: Shimizu T; Departments of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan., Kawashiri SY; Departments of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Departments of Community Medicine, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Koga T; Departments of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Kiya R; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan., Morita M; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan., Kuroda S; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan., Tashiro S; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan., Morimoto S; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan., Yano H; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan., Ueki Y; Department of Rheumatology, Hakujyujikai Sasebo Chuo Hospital, Sasebo, Japan., Dobashi H; Division of Rheumatology, Department of Internal Medicine, Kagawa University Hospital, Kagawa, Japan., Nozaki Y; Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka, Japan., Hosogaya N; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan., Yamamoto H; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan., Kawakami A; Departments of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Source: Global health & medicine [Glob Health Med] 2025 Aug 31; Vol. 7 (4), pp. 334-339.
Publication Type: Letter
Journal Info: Publisher: National Center for Global Health and Medicine Country of Publication: Japan NLM ID: 101771579 Publication Model: Print Cited Medium: Internet ISSN: 2434-9194 (Electronic) Linking ISSN: 24349186 NLM ISO Abbreviation: Glob Health Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2434-9194
DOI:10.35772/ghm.2025.01054